A significant contaminant of the antimalarial drug piperaquine (1,3-bis-[4-(7-chloroquinolyl-4)-piperazinyl-1]-propane) has been identified using liquid chromatography–mass spectrometry (LC–MS) and 2D-NMR Spectroscopy (1H-1H COSY, 1H-13C HSQC, 1H-13C HMBC). The impurity was identified as the positional isomer 1-[(5-chloroquinolin-4)-piperazinyl]-3-[(7-chloroquinolin-4)-piperazinyl]-propane. The impurity is probably formed because of contamination of batches of 4,7-dichloroquinoline (a precursor in the synthesis of piperaquine) with 4,5-dichloroquinoline. The amount of impurity (peak area impurity/peak area piperaquine using LC-UV at 347 nm) in old batches of piperaquine and in ArtekinTM (the combination of dihydroartemisinin-piperaquine) ranged from 1.5-5%.
N. Lindegårdh, F. Giorgi, B. Galletti, M. Di Mattia, M. Quaglia, D. Carnevale, et al. (2006). Identification of an isomer impurity in piperaquine drug substances. JOURNAL OF CHROMATOGRAPHY A, 1135, 166-169 [10.1016/j.chroma.2006.09.066].
Identification of an isomer impurity in piperaquine drug substances
MAZZANTI, ANDREA;
2006
Abstract
A significant contaminant of the antimalarial drug piperaquine (1,3-bis-[4-(7-chloroquinolyl-4)-piperazinyl-1]-propane) has been identified using liquid chromatography–mass spectrometry (LC–MS) and 2D-NMR Spectroscopy (1H-1H COSY, 1H-13C HSQC, 1H-13C HMBC). The impurity was identified as the positional isomer 1-[(5-chloroquinolin-4)-piperazinyl]-3-[(7-chloroquinolin-4)-piperazinyl]-propane. The impurity is probably formed because of contamination of batches of 4,7-dichloroquinoline (a precursor in the synthesis of piperaquine) with 4,5-dichloroquinoline. The amount of impurity (peak area impurity/peak area piperaquine using LC-UV at 347 nm) in old batches of piperaquine and in ArtekinTM (the combination of dihydroartemisinin-piperaquine) ranged from 1.5-5%.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
